MedPath

Contrast Induced Acute Kidney in Patients With Acute Stroke

Conditions
Stroke, Acute
Interventions
Drug: Radiopaque Media
Registration Number
NCT03132558
Lead Sponsor
Nanjing Medical University
Brief Summary

Computed tomographic angiography (CTA) is recommended for identifying eligible patient with acute ischemic stroke (AIS) to receieve endovascular treatment. We are going to conduct this prospective corhot study to observe if sequential use contrast in CTA examination and in endovascular treatment will cause acute kidney injury.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • All patients who are suspected with AIS.
  • Non-contrast head CT excludes intracranial hemorrhage.
Exclusion Criteria
  • Lacking of pre-CTA Creatinine
  • Lacking of post-angiography Creatinine with 24-48 hours

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CTA+DSARadiopaque MediaPatients with AIS receieved cerebral CTA, followed by endovascular treatment with the guidence of digital substration angiography (DSA).
CTARadiopaque MediaPatients with AIS only receieved cerebral CTA exam.
Primary Outcome Measures
NameTimeMethod
Creatininewithin 24h to 48h

Contrast-induced acute kidney injury was defined as a relative increase of 25% or an absolute increase of 0.3 mg/dL (28.2mol/L) in the serum creatinine level at 48 hours following angiography

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The First Affiliated Hospital of Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath